首页 > 最新文献

Biomedical reports最新文献

英文 中文
Bacterial classification based on metagenomic analysis in peritoneal dialysis effluent of patients with chronic kidney disease 基于元基因组分析的慢性肾病患者腹膜透析出水中的细菌分类
IF 2.3 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-05-14 DOI: 10.3892/br.2024.1790
S. Visedthorn, Pavit Klomkliew, Vorthon Sawaswong, Pavaret Sivapornnukul, Prangwalai Chanchaem, T. Saejew, P. Pavatung, T. Kanjanabuch, S. Payungporn
{"title":"Bacterial classification based on metagenomic analysis in peritoneal dialysis effluent of patients with chronic kidney disease","authors":"S. Visedthorn, Pavit Klomkliew, Vorthon Sawaswong, Pavaret Sivapornnukul, Prangwalai Chanchaem, T. Saejew, P. Pavatung, T. Kanjanabuch, S. Payungporn","doi":"10.3892/br.2024.1790","DOIUrl":"https://doi.org/10.3892/br.2024.1790","url":null,"abstract":"","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140978370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time‑dependent ROC curve analysis to determine the predictive capacity of seven clinical scales for mortality in patients with COVID‑19: Study of a hospital cohort with very high mortality 确定七个临床量表对 COVID-19 患者死亡率预测能力的时间依赖性 ROC 曲线分析:对死亡率极高的医院队列的研究
IF 2.3 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-05-09 DOI: 10.3892/br.2024.1788
Martha A Mendoza-Hernandez, Gustavo A. Hernández-Fuentes, C. Sánchez-Ramírez, Fabián Rojas-Larios, J. Guzmán-Esquivel, I. Rodríguez-Sánchez, M. Martinez-Fierro, M. Cárdenas-Rojas, Luis de-Leon-Zaragoza, Benjamin Trujillo‑Hernandez, Mercedes Fuentes‑Murguia, H. Ochoa-Díaz-López, Karmina Sánchez‑Meza, Iván Delgado-Enciso
Clinical data from hospital admissions are typically utilized to determine the prognostic capacity of Coronavirus disease 2019 (COVID-19) indices. However, as disease status and severity markers evolve over time, time-dependent receiver operating characteristic (ROC) curve analysis becomes more appropriate. The present analysis assessed predictive power for death at various time points throughout patient hospitalization. In a cohort study involving 515 hospitalized patients (General Hospital Number 1 of Mexican Social Security Institute, Colima, Mexico from February 2021 to December 2022) with COVID-19, seven severity indices [Pneumonia Severity Index (PSI) PaO2/FiO2 arterial oxygen pressure/fraction of inspired oxygen (Kirby index), the Critical Illness Risk Score (COVID-GRAM), the National Early Warning Score 2 (NEWS-2), the quick Sequential Organ Failure Assessment score (qSOFA), the Fibrosis-4 index (FIB-4) and the Viral Pneumonia Mortality Score (MuLBSTA were evaluated using time-dependent ROC curves. Clinical data were collected at admission and at 2, 4, 6 and 8 days into hospitalization. The study calculated the area under the curve (AUC), sensitivity, specificity, and predictive values for each index at these time points. Mortality was 43.9%. Throughout all time points, NEWS-2 demonstrated the highest predictive power for mortality, as indicated by its AUC values. PSI and COVID-GRAM followed, with predictive power increasing as hospitalization duration progressed. Additionally, NEWS-2 exhibited the highest sensitivity (>96% in all periods) but showed low specificity, which increased from 22.9% at admission to 58.1% by day 8. PSI displayed good predictive capacity from admission to day 6 and excellent predictive power at day 8 and its sensitivity remained >80% throughout all periods, with moderate specificity (70.6-77.3%). COVID-GRAM demonstrated good predictive capacity across all periods, with high sensitivity (84.2-87.3%) but low-to-moderate specificity (61.5-67.6%). The qSOFA index initially had poor predictive power upon admission but improved after 4 days. FIB-4 had a statistically significant predictive capacity in all periods (P=0.001), but with limited clinical value (AUC, 0.639-0.698), and with low sensitivity and specificity. MuLBSTA and IKIRBY exhibited low predictive power at admission and no power after 6 days. In conclusion, in COVID-19 patients with high mortality rates, NEWS-2 and PSI consistently exhibited predictive power for death during hospital stay, with PSI demonstrating the best balance between sensitivity and specificity.
通常利用入院的临床数据来确定冠状病毒疾病 2019(COVID-19)指数的预后能力。然而,随着时间的推移,疾病状态和严重程度标志物也会发生变化,因此进行随时间变化的接收者操作特征(ROC)曲线分析更为合适。本分析评估了患者住院期间不同时间点的死亡预测能力。重症风险评分 (COVID-GRAM)、国家预警评分 2 (NEWS-2)、快速序贯器官衰竭评估评分 (qSOFA)、纤维化-4 指数 (FIB-4) 和病毒性肺炎死亡率评分 (MuLBSTA) 等。研究收集了患者入院时以及住院 2、4、6 和 8 天时的临床数据。研究计算了各指标在这些时间点的曲线下面积(AUC)、灵敏度、特异性和预测值。死亡率为 43.9%。在所有时间点上,NEWS-2 的 AUC 值都显示出对死亡率的最高预测能力。其次是 PSI 和 COVID-GRAM,预测能力随着住院时间的延长而增强。此外,NEWS-2 的灵敏度最高(在所有时间段均大于 96%),但特异性较低,从入院时的 22.9% 增加到第 8 天的 58.1%。PSI 在入院至第 6 天期间显示出良好的预测能力,在第 8 天显示出卓越的预测能力,其灵敏度在所有时间段内均大于 80%,特异性适中(70.6%-77.3%)。COVID-GRAM 在所有时期都表现出良好的预测能力,灵敏度高(84.2-87.3%),但特异性低至中等(61.5-67.6%)。qSOFA 指数在入院初期的预测能力较差,但在 4 天后有所改善。FIB-4 在所有时期的预测能力均有统计学意义(P=0.001),但临床价值有限(AUC,0.639-0.698),敏感性和特异性均较低。MuLBSTA 和 IKIRBY 在入院时的预测能力较低,6 天后则没有预测能力。总之,在死亡率较高的 COVID-19 患者中,NEWS-2 和 PSI 始终具有预测住院期间死亡的能力,其中 PSI 在灵敏度和特异性之间表现出最佳平衡。
{"title":"Time‑dependent ROC curve analysis to determine the predictive capacity of seven clinical scales for mortality in patients with COVID‑19: Study of a hospital cohort with very high mortality","authors":"Martha A Mendoza-Hernandez, Gustavo A. Hernández-Fuentes, C. Sánchez-Ramírez, Fabián Rojas-Larios, J. Guzmán-Esquivel, I. Rodríguez-Sánchez, M. Martinez-Fierro, M. Cárdenas-Rojas, Luis de-Leon-Zaragoza, Benjamin Trujillo‑Hernandez, Mercedes Fuentes‑Murguia, H. Ochoa-Díaz-López, Karmina Sánchez‑Meza, Iván Delgado-Enciso","doi":"10.3892/br.2024.1788","DOIUrl":"https://doi.org/10.3892/br.2024.1788","url":null,"abstract":"Clinical data from hospital admissions are typically utilized to determine the prognostic capacity of Coronavirus disease 2019 (COVID-19) indices. However, as disease status and severity markers evolve over time, time-dependent receiver operating characteristic (ROC) curve analysis becomes more appropriate. The present analysis assessed predictive power for death at various time points throughout patient hospitalization. In a cohort study involving 515 hospitalized patients (General Hospital Number 1 of Mexican Social Security Institute, Colima, Mexico from February 2021 to December 2022) with COVID-19, seven severity indices [Pneumonia Severity Index (PSI) PaO2/FiO2 arterial oxygen pressure/fraction of inspired oxygen (Kirby index), the Critical Illness Risk Score (COVID-GRAM), the National Early Warning Score 2 (NEWS-2), the quick Sequential Organ Failure Assessment score (qSOFA), the Fibrosis-4 index (FIB-4) and the Viral Pneumonia Mortality Score (MuLBSTA were evaluated using time-dependent ROC curves. Clinical data were collected at admission and at 2, 4, 6 and 8 days into hospitalization. The study calculated the area under the curve (AUC), sensitivity, specificity, and predictive values for each index at these time points. Mortality was 43.9%. Throughout all time points, NEWS-2 demonstrated the highest predictive power for mortality, as indicated by its AUC values. PSI and COVID-GRAM followed, with predictive power increasing as hospitalization duration progressed. Additionally, NEWS-2 exhibited the highest sensitivity (>96% in all periods) but showed low specificity, which increased from 22.9% at admission to 58.1% by day 8. PSI displayed good predictive capacity from admission to day 6 and excellent predictive power at day 8 and its sensitivity remained >80% throughout all periods, with moderate specificity (70.6-77.3%). COVID-GRAM demonstrated good predictive capacity across all periods, with high sensitivity (84.2-87.3%) but low-to-moderate specificity (61.5-67.6%). The qSOFA index initially had poor predictive power upon admission but improved after 4 days. FIB-4 had a statistically significant predictive capacity in all periods (P=0.001), but with limited clinical value (AUC, 0.639-0.698), and with low sensitivity and specificity. MuLBSTA and IKIRBY exhibited low predictive power at admission and no power after 6 days. In conclusion, in COVID-19 patients with high mortality rates, NEWS-2 and PSI consistently exhibited predictive power for death during hospital stay, with PSI demonstrating the best balance between sensitivity and specificity.","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140995734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beneficial changes in gut microbiota after phototherapy for neonatal hyperbilirubinemia 光疗治疗新生儿高胆红素血症后肠道微生物群发生有益变化
IF 2.3 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-05-09 DOI: 10.3892/br.2024.1789
Rang Wu, Yazhou Jiang, Jingjing Yan, Nan Shen, Song Liu, H. Yin, Suyue Zhu, Jibing Qiao
Phototherapy is the most commonly used treatment for neonatal hyperbilirubinemia (NH). Gut microbiota is involved in bilirubin metabolism; however, it is uncertain whether this is affected by phototherapy. The present study included 43 newborns with hyperbilirubinemia and collected fecal samples for high-throughput sequencing before and after phototherapy. Selection α diversity analysis was used to determine the differences in diversity and abundance between the two groups, whereas similarity was determined using β diversity analysis. Linear discriminant analysis effect size analysis was used to screen for markedly different bacteria. The structure of the gut microbiota in newborns with hyperbilirubinemia changed after phototherapy, with a significant decrease in abundance and diversity. The changes in the key bacterial species were characterized by an increase in the abundance of Streptococcus salivarius and a decrease in the abundance of Escherichia, Klebsiella pneumoniae, Rothia mucilaginosa and Streptococcus oralis. These changes mainly manifested as an increase in beneficial bacteria and a decrease in opportunistic bacteria, which may not be related to the side effects of phototherapy. These results can provide theoretical assistance for microbiological research on the later stages of NH.
光疗是治疗新生儿高胆红素血症(NH)最常用的方法。肠道微生物群参与胆红素代谢,但目前还不确定光疗是否会影响肠道微生物群。本研究纳入了 43 名患有高胆红素血症的新生儿,并收集了光疗前后的粪便样本进行高通量测序。选择α多样性分析用于确定两组之间多样性和丰度的差异,而相似性则使用β多样性分析确定。线性判别分析效应大小分析用于筛选明显不同的细菌。光疗后,高胆红素血症新生儿肠道微生物群的结构发生了变化,丰度和多样性显著下降。主要细菌种类的变化特点是唾液链球菌的数量增加,而埃希氏菌、肺炎克雷伯菌、粘液罗氏菌和口腔链球菌的数量减少。这些变化主要表现为有益菌的增加和机会性细菌的减少,这可能与光疗的副作用无关。这些结果可为后期 NH 的微生物研究提供理论帮助。
{"title":"Beneficial changes in gut microbiota after phototherapy for neonatal hyperbilirubinemia","authors":"Rang Wu, Yazhou Jiang, Jingjing Yan, Nan Shen, Song Liu, H. Yin, Suyue Zhu, Jibing Qiao","doi":"10.3892/br.2024.1789","DOIUrl":"https://doi.org/10.3892/br.2024.1789","url":null,"abstract":"Phototherapy is the most commonly used treatment for neonatal hyperbilirubinemia (NH). Gut microbiota is involved in bilirubin metabolism; however, it is uncertain whether this is affected by phototherapy. The present study included 43 newborns with hyperbilirubinemia and collected fecal samples for high-throughput sequencing before and after phototherapy. Selection α diversity analysis was used to determine the differences in diversity and abundance between the two groups, whereas similarity was determined using β diversity analysis. Linear discriminant analysis effect size analysis was used to screen for markedly different bacteria. The structure of the gut microbiota in newborns with hyperbilirubinemia changed after phototherapy, with a significant decrease in abundance and diversity. The changes in the key bacterial species were characterized by an increase in the abundance of Streptococcus salivarius and a decrease in the abundance of Escherichia, Klebsiella pneumoniae, Rothia mucilaginosa and Streptococcus oralis. These changes mainly manifested as an increase in beneficial bacteria and a decrease in opportunistic bacteria, which may not be related to the side effects of phototherapy. These results can provide theoretical assistance for microbiological research on the later stages of NH.","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140995683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combining KRAS gene status with preoperative D‑dimer levels as a predictive marker of venous thromboembolism risk in patients with resectable colorectal cancer: A prospective cohort study 将 KRAS 基因状态与术前 D-二聚体水平相结合,作为可切除结直肠癌患者静脉血栓栓塞风险的预测指标:前瞻性队列研究
IF 2.3 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-04-22 DOI: 10.3892/br.2024.1784
Duogang Xu, Yulei He, Changkang Liao, Jing Tan
{"title":"Combining KRAS gene status with preoperative D‑dimer levels as a predictive marker of venous thromboembolism risk in patients with resectable colorectal cancer: A prospective cohort study","authors":"Duogang Xu, Yulei He, Changkang Liao, Jing Tan","doi":"10.3892/br.2024.1784","DOIUrl":"https://doi.org/10.3892/br.2024.1784","url":null,"abstract":"","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140673468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound‑guided erector spinae plane block in posterior lumbar surgery (Review) 腰椎后路手术中的超声引导竖脊肌平面阻滞(综述)
IF 2.3 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-04-22 DOI: 10.3892/br.2024.1783
Ke Deng, Kui Huang, Guo-Feng Wu
{"title":"Ultrasound‑guided erector spinae plane block in posterior lumbar surgery (Review)","authors":"Ke Deng, Kui Huang, Guo-Feng Wu","doi":"10.3892/br.2024.1783","DOIUrl":"https://doi.org/10.3892/br.2024.1783","url":null,"abstract":"","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140677423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiocontrast medium induces histamine release in association with upregulation of miR‑19a‑3p and miR‑362‑3p expression 放射对比介质诱导组胺释放与 miR-19a-3p 和 miR-362-3p 表达上调有关
IF 2.3 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-04-19 DOI: 10.3892/br.2024.1780
Wei-Fang Chang, Po-Wei Huang, Chia-Ling Li, Hung-Sen Huang, Ting-Yu Chou, En-Chih Liao, Sheng-Jie Yu
{"title":"Radiocontrast medium induces histamine release in association with upregulation of miR‑19a‑3p and miR‑362‑3p expression","authors":"Wei-Fang Chang, Po-Wei Huang, Chia-Ling Li, Hung-Sen Huang, Ting-Yu Chou, En-Chih Liao, Sheng-Jie Yu","doi":"10.3892/br.2024.1780","DOIUrl":"https://doi.org/10.3892/br.2024.1780","url":null,"abstract":"","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140683237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applications and challenges of neural networks in otolaryngology (Review) 耳鼻喉科神经网络的应用与挑战(综述)
IF 2.3 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-04-19 DOI: 10.3892/br.2024.1781
Iulian-Alexandru Taciuc, M. Dumitru, Daniela Vrinceanu, Mirela Gherghe, F. Manole, A. Marinescu, Crenguta Serboiu, A. Neagos, Adrian Costache
{"title":"Applications and challenges of neural networks in otolaryngology (Review)","authors":"Iulian-Alexandru Taciuc, M. Dumitru, Daniela Vrinceanu, Mirela Gherghe, F. Manole, A. Marinescu, Crenguta Serboiu, A. Neagos, Adrian Costache","doi":"10.3892/br.2024.1781","DOIUrl":"https://doi.org/10.3892/br.2024.1781","url":null,"abstract":"","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140682608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ω‑3 fatty acids in atherosclerotic cardiovascular disease (Review) 动脉粥样硬化性心血管疾病中的ω-3 脂肪酸(综述)
IF 2.3 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-04-19 DOI: 10.3892/br.2024.1782
Xingxing Xie, Xue Liu, Rong Li, Ling Fan, Fujing Huang
{"title":"ω‑3 fatty acids in atherosclerotic cardiovascular disease (Review)","authors":"Xingxing Xie, Xue Liu, Rong Li, Ling Fan, Fujing Huang","doi":"10.3892/br.2024.1782","DOIUrl":"https://doi.org/10.3892/br.2024.1782","url":null,"abstract":"","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140682926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of lurasidone for schizophrenia: A systematic review and meta‑analysis of eight short‑term, randomized, double‑blind, placebo‑controlled clinical trials 鲁拉西酮治疗精神分裂症的疗效和安全性:八项短期、随机、双盲、安慰剂对照临床试验的系统回顾和荟萃分析
IF 2.3 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-04-11 DOI: 10.3892/br.2024.1779
Shan Gao, Ling Fan, Zhigang Yu, Xingxing Xie
{"title":"Efficacy and safety of lurasidone for schizophrenia: A systematic review and meta‑analysis of eight short‑term, randomized, double‑blind, placebo‑controlled clinical trials","authors":"Shan Gao, Ling Fan, Zhigang Yu, Xingxing Xie","doi":"10.3892/br.2024.1779","DOIUrl":"https://doi.org/10.3892/br.2024.1779","url":null,"abstract":"","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140714919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
miRNA‑mRNA network contributes to HBV‑related hepatocellular carcinoma via immune infiltration induced by GRB2 miRNA-mRNA网络通过GRB2诱导的免疫浸润导致HBV相关肝细胞癌
IF 2.3 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-04-11 DOI: 10.3892/br.2024.1777
C. Zheng, Hongmeng Su, Min Liu, Yanyan Qian, Hong Fan
{"title":"miRNA‑mRNA network contributes to HBV‑related hepatocellular carcinoma via immune infiltration induced by GRB2","authors":"C. Zheng, Hongmeng Su, Min Liu, Yanyan Qian, Hong Fan","doi":"10.3892/br.2024.1777","DOIUrl":"https://doi.org/10.3892/br.2024.1777","url":null,"abstract":"","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140715138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedical reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1